Walgreens has announced a $10 billion deal with private equity firm Sycamore Partners to take the struggling drugstore chain private, ending its nearly century-long run as a public company. The deal, expected to close in Q4 2025, includes an $11.45 per-share cash offer with potential additional payouts, bringing the total transaction value up to $23.7 billion, including debt. Facing significant challenges such as declining retail pharmacy profitability, competition from CVS and Amazon, and a faltering healthcare expansion strategy, Walgreens has been closing stores and restructuring operations.
Walgreens to go private in roughly $10 billion deal with Sycamore Partners (CNBC)
0